TASLY PHARMACEUTICAL

tasly-pharmaceutical-logo

Tasly is pioneering the most aggressive paradigm shift in modern medicine: scientifically proving that the 5,000-year old medical practice of Modern Traditional Chinese Medicine (mTCM) – healing the body with pure, natural herbs, is as effective as treating it with chemical and synthetic drug compounds. This will fulfill an unmet clinical need for healthcare providers and patients alike by being able to treat serious diseases with chemical-free products, which could be a game changer in modern medicine.

#SimilarOrganizations #People #Financial #Website #More

TASLY PHARMACEUTICAL

Social Links:

Industry:
Biotechnology Pharmaceutical

Founded:
1994-01-01

Address:
Tianjin, Guangdong, China

Country:
China

Website Url:
http://www.taslyint.com

Total Employee:
10001+

Status:
Active

Contact:
+02226736290

Technology used in webpage:
Google Font API Content Delivery Network Facebook Conversion Tracking MediaElement.js Twitter Tweet Button Alibaba HiChina DNS LiveChat


Similar Organizations

beacon-pharmaceuticals-logo

Beacon Pharmaceuticals

Beacon Pharmaceuticals is a oncology company that manufactures generic drugs, biotech, hi-tech & conventional general products.

pci-pharma-services-logo

PCI Pharma Services

PCI Pharma Services is a provider of outsourced services to the global pharmaceutical market.

purdue-pharma-logo

Purdue Pharma

Purdue Pharma L.P., a pharmaceutical company committed to improving patients' lives and serving the healthcare community.

samjin-pharmaceutical-logo

Samjin Pharmaceutical

Samjin Pharmaceutical is a company that pioneeres a healthy life for human beings with a creative mind and advances for a prosperous future.


Current Advisors List

yan-kaijing_image

Yan Kaijing Secretary of the Party Committee and Chairman of the Board @ Tasly Pharmaceutical
Board_member

Current Employees Featured

not_available_image

HENRY SUN
HENRY SUN President and CEO @ Tasly Pharmaceutical
President and CEO
2006-01-01

Stock Details


Company's stock symbol is SSE:600535

Investments List

Date Company Article Money raised
2019-01-07 Zhangshang Tangyi Tasly Pharmaceutical investment in Series C - Zhangshang Tangyi 100 M USD
2018-08-14 Profusa Tasly Pharmaceutical investment in Series C - Profusa 45 M USD
2018-06-29 I-Mab Biopharma Tasly Pharmaceutical investment in Series C - I-Mab Biopharma 220 M USD
2018-04-11 Shuwen Biotech Tasly Pharmaceutical investment in Series A - Shuwen Biotech N/A
2017-03-23 I-Mab Biopharma Tasly Pharmaceutical investment in Series B - I-Mab Biopharma 150 M USD
2017-03-22 Xiaoyusan Tasly Pharmaceutical investment in Series B - Xiaoyusan 100 M CNY
2017-01-03 Ascletis Tasly Pharmaceutical investment in Series B - Ascletis 100 M USD
2015-09-02 Ascletis Tasly Pharmaceutical investment in Series B - Ascletis 35 M USD

Official Site Inspections

http://www.taslyint.com

Unable to get host informations!!!

Loading ...

More informations about "Tasly Pharmaceutical" on Search Engine